Amir Hossein Babaei

Amir Hossein Babaei

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
RSR. Sharifi
R. Sharifi
Reza FekrazadReza Fekrazad
Reza Fekrazad
MTM.M. Taheri
M.M. Taheri
AKA. Kasaeian
A. Kasaeian
ABAmir Hossein Babaei
Amir Hossein Babaei

24 April 2020 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
SHSeyed Basir Hashemi
Seyed Basir Hashemi
HBHaleh Bozorgi
Haleh Bozorgi
TKTAYEBEH KAZEMI
TAYEBEH KAZEMI
ABAmir Hossein Babaei
Amir Hossein Babaei
Introduction: Cochlear implants (CI) is considered a safe procedure with overall complication rate of 12.5% amongst adult and pediatric population. Cerebrospinal fluid (CSF) gusher is regarded as a common CI intraoperative complication. Objective: In this study, we determined the association between probable associated factors and occurrence of intraoperative CSF gusher. Method: In a retrospective survey, 394 patients with severe to profound sensorineural hearing loss who underwent primary cochlear implantation surgery were evaluated. Patients with incomplete electronic or manual file and those with revision, explantation or reimplantation surgery were excluded. Result: There hundred and ninety-four CI patients with a mean age of 8.74 ± 12.21 years were reviewed 49.62% of them were female. CSF gusher developed in 22 patients (5.58%). Patients with CSF gusher had more structural abnormalities in their CT scans’ report. The prevalence of Mondini dysplasia and common cavity malformation were the most common abnormal reports amongst those with intraoperative CSF gusher. Conclusion: In conclusion, cochlea structural abnormalities affect the incidence of CSF gusher in CI recipients. Common cavity malformation and Mondini dysplasia significantly increase the incidence of latter complication. We insist on more precise pre-operative imaging of those with abnormal cochlea structures to provide the needed management.

1 January 2020 in Indian Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
STSeyed Alireza Taghavi
Seyed Alireza Taghavi
ABAmir Hossein Babaei
Amir Hossein Babaei
AMAli Mohammadi
Ali Mohammadi
MMMohammad Amin Mahdiyar
Mohammad Amin Mahdiyar
PIPooya Iranpour
Pooya Iranpour
AMAbdolali Mohagheghzadeh
Abdolali Mohagheghzadeh
OBJECTIVES: The aim of this study is to investigate the therapeutic property of hydroalcoholic extract of Fenugreek seeds in nonalcoholic fatty liver disease (NAFLD) in adult patients. METHODS: This randomized, placebo-controlled, parallel trial was conducted from November 2014 to June 2017. Patients aged between 18 and 70 years old with confirmed NAFLD were recruited from the Motahhari clinic, affiliated to Shiraz University of Medical Sciences, Iran. Participants either received 1 g hydroalcoholic extract of Fenugreek seeds or placebo daily for 3 months. The primary outcomes were changes in serum alanine transaminase and FibroScan controlled attenuation parameter score. Secondary outcome measures were changes in other laboratory data, liver stiffness measure, liver steatosis percent, and anthropometric variables. Participants were randomly assigned to the groups using blocked randomization method. Participants, investigators, and statistician were blinded to treatments allocation. RESULTS: After screening eighty patients, thirty patients met the inclusion criteria and were divided into two groups (1:1). After 3 months, two and four patients did not complete the trial in Fenugreek and placebo group, respectively. The changes in the anthropometrics, laboratories and FibroScan measurements were not statistically significant between the two groups. CONCLUSION: The evidence to prove the efficacy of the Fenugreek seeds' hydroalcoholic extract in NAFLD was not strong enough; hence, further experiments are still needed to assess the possible efficacy of Fenugreek on the treatment of NAFLD.


2 November 2021 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
ABAmir Hossein Babaei
Amir Hossein Babaei
KIKamyar Iravani
Kamyar Iravani
BMBehzad Malekpour
Behzad Malekpour
BGBehnaz Golkhar
Behnaz Golkhar
ASAmir Soltaniesmaeili
Amir Soltaniesmaeili
MHMilad Hosseinialhashemi
Milad Hosseinialhashemi
Objectives: The present study aimed to assess the 4‐ and 8‐week recovery rate of anosmia and determine the factors associated with recovery in COVID‐19 patients.Method: This retrospective study was conducted from December 2020 to March 2021. RT‐PCR‐proven COVID‐19 adult patients (over 18 years of age) with a positive history of anosmia were included in this study. Anosmia was assessed based on the COVID‐19 Anosmia Reporting Tool. The recovery rate of anosmia after 4 and 8 weeks were evaluated, and the relationship between the patients' recovery and their clinical and demographic data was assessed.Results: A total of 235 patients were included. Their mean age (±SD) was 43.95 ± 15.27 years. Anosmia recovery was reported in 207(88.51%) and 219 (93.19%) participants till 4 and 8 weeks. The mean recovery time was 19.42 ± 8.81 days. The result of logistic regression showed that smoking (P = .031; OR = 10.813), ageusia (P = .002; OR = 5.340), headache (P = .006; OR = 0.243), and nasal discharge (P < .001; OR = 0.080) were significantly associated with 4 weeks anosmia recovery. The only risk factor which was associated with a lower rate of 8 weeks anosmia recovery was presence of nasal discharge (OR = 0.106, P = .002).Conclusion: The only risk factor which was associated with a lower rate of 8 weeks anosmia recovery was presence of nasal discharge. Our result demonstrated that although smoking was associated with higher recovery rate till 4 weeks, it could not be considered as a protective factor after 8 weeks. More studies are recommended to investigate the relationship between anosmia and the associated factors by consideration of both short‐ and long‐term recovery rates and assess the possible mechanisms that could justify this association.Levels of Evidence: 3b

22 August 2016 in Nephro-Urology Monthly
Verified
Journal Article
Open access
PDF file
MSMehdi Shirazi
Mehdi Shirazi
AAAli Ariafar
Ali Ariafar
ABAmir Hossein Babaei
Amir Hossein Babaei
AAAbdosamad Ashrafzadeh
Abdosamad Ashrafzadeh
AAAli Adib
Ali Adib
Background: Urethrocutaneous fistula (UCF) is the most prevalent complication after hypospadias repair surgery. Many methods have been developed for UCF correction, and the best technique for UCF repair is determined based on the size, location, and number of fistulas, as well as the status of the surrounding skin. Objectives: In this study, we introduced and evaluated a simple method for UCF correction after tubularized incised plate (TIP) repair. Methods: This clinical study was conducted on children with UCFs ≤ 4 mm that developed after TIP surgery for hypospadias repair. The skin was incised around the fistula and the tract was released from the surrounding tissues and the dartos fascia, then ligated with 5 - 0 polydioxanone (PDS) sutures. The dartos fascia, as the second layer, was covered on the fistula tract with PDS thread (gauge 5 - 0) by the continuous suture method. The skin was closed with 6 - 0 Vicryl sutures. After six months of follow-up, surgical outcomes were evaluated based on fistula relapse and other complications. Results: After six months, relapse occurred in only one patient, a six-year-old boy with a single 4-mm distal opening, who had undergone no previous fistula repairs. Therefore, in 97.5% of the cases, relapse was non-existent. Other complications, such as urethral stenosis, intraurethral obstruction, and epidermal inclusion cysts, were not seen in the other patients during the six-month follow-up period. Conclusions: This repair method, which is simple, rapid, and easily learned, is highly applicable, with a high success rate for the closure of UCFs measuring up to 4 mm in any location. Keywords: Urethrocutaneous Fistula; Hypospadias; Tubularized Incised Plate Repair